AccessPak for HIV PEP Expanded with Kaletra and Tinzaparin Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Tinzaparin Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: tinzaparin
Brand name:
Synonyms: Tinzaparin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Tiotropium
- AccessPak for HIV PEP Expanded with Kaletra-Tiotropium and Olodaterol
- AccessPak for HIV PEP Expanded with Kaletra-Tiotropium and olodaterol Inhalation
- AccessPak for HIV PEP Expanded with Kaletra-Tiotropium Bromide
- AccessPak for HIV PEP Expanded with Kaletra-Tiotropium Capsules for Inhalation
- AccessPak for HIV PEP Expanded with Kaletra-Tiotropium inhalation
- Tinzaparin Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Tinzaparin Subcutaneous-Accolate
- Tinzaparin Subcutaneous-Accretropin
- Tinzaparin Subcutaneous-Accucaine
- Tinzaparin Subcutaneous-AccuHist Drops
- Tinzaparin Subcutaneous-AccuHist PDX Drops